268 related articles for article (PubMed ID: 18055564)
21. Proton MR spectroscopy of tumefactive demyelinating lesions.
Saindane AM; Cha S; Law M; Xue X; Knopp EA; Zagzag D
AJNR Am J Neuroradiol; 2002 Sep; 23(8):1378-86. PubMed ID: 12223381
[TBL] [Abstract][Full Text] [Related]
22. The role of dynamic susceptibility contrast-enhanced perfusion MR imaging in differentiating between infectious and neoplastic focal brain lesions: results from a cohort of 100 consecutive patients.
Floriano VH; Torres US; Spotti AR; Ferraz-Filho JR; Tognola WA
PLoS One; 2013; 8(12):e81509. PubMed ID: 24324699
[TBL] [Abstract][Full Text] [Related]
23. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
[TBL] [Abstract][Full Text] [Related]
24. Differentiation of hemangioblastomas from pilocytic astrocytomas using 3-T magnetic resonance perfusion-weighted imaging and MR spectroscopy.
She DJ; Xing Z; Zeng Z; Shang XY; Cao DR
Neuroradiology; 2015 Mar; 57(3):275-81. PubMed ID: 25487356
[TBL] [Abstract][Full Text] [Related]
25. Differentiating Radiation-Induced Necrosis from Recurrent Brain Tumor Using MR Perfusion and Spectroscopy: A Meta-Analysis.
Chuang MT; Liu YS; Tsai YS; Chen YC; Wang CK
PLoS One; 2016; 11(1):e0141438. PubMed ID: 26741961
[TBL] [Abstract][Full Text] [Related]
26. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
[TBL] [Abstract][Full Text] [Related]
27. Accuracy of single-voxel proton MR spectroscopy in distinguishing neoplastic from nonneoplastic brain lesions.
Rand SD; Prost R; Haughton V; Mark L; Strainer J; Johansen J; Kim TA; Chetty VK; Mueller W; Meyer G; Krouwer H
AJNR Am J Neuroradiol; 1997 Oct; 18(9):1695-704. PubMed ID: 9367317
[TBL] [Abstract][Full Text] [Related]
28. Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy.
Schlemmer HP; Bachert P; Herfarth KK; Zuna I; Debus J; van Kaick G
AJNR Am J Neuroradiol; 2001 Aug; 22(7):1316-24. PubMed ID: 11498420
[TBL] [Abstract][Full Text] [Related]
29. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas.
Li X; Jin H; Lu Y; Oh J; Chang S; Nelson SJ
NMR Biomed; 2004 Feb; 17(1):10-20. PubMed ID: 15011246
[TBL] [Abstract][Full Text] [Related]
30. In vivo single-voxel proton MR spectroscopy in brain lesions with ring-like enhancement.
Kimura T; Sako K; Gotoh T; Tanaka K; Tanaka T
NMR Biomed; 2001 Oct; 14(6):339-49. PubMed ID: 11599032
[TBL] [Abstract][Full Text] [Related]
31. Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging.
Zonari P; Baraldi P; Crisi G
Neuroradiology; 2007 Oct; 49(10):795-803. PubMed ID: 17619871
[TBL] [Abstract][Full Text] [Related]
32. Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions.
Smith EA; Carlos RC; Junck LR; Tsien CI; Elias A; Sundgren PC
AJR Am J Roentgenol; 2009 Feb; 192(2):W45-52. PubMed ID: 19155380
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
34. Cutoff value of choline concentration reliably reveals high-grade brain tumors among other contrast-enhancing brain lesions.
Porto L; Hattingen E; Stuecher A; Herminghaus S; Lanfermann H; Ulrich Pilatus UP
J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):147-52. PubMed ID: 22190143
[TBL] [Abstract][Full Text] [Related]
35. Proton MR spectroscopy improves discrimination between tumor and pseudotumoral lesion in solid brain masses.
Majós C; Aguilera C; Alonso J; Julià-Sapé M; Castañer S; Sánchez JJ; Samitier A; León A; Rovira A; Arús C
AJNR Am J Neuroradiol; 2009 Mar; 30(3):544-51. PubMed ID: 19095788
[TBL] [Abstract][Full Text] [Related]
36. Differentiation of glioblastoma multiforme from metastatic brain tumor using proton magnetic resonance spectroscopy, diffusion and perfusion metrics at 3 T.
Tsougos I; Svolos P; Kousi E; Fountas K; Theodorou K; Fezoulidis I; Kapsalaki E
Cancer Imaging; 2012 Oct; 12(3):423-36. PubMed ID: 23108208
[TBL] [Abstract][Full Text] [Related]
37. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue.
Sugahara T; Korogi Y; Tomiguchi S; Shigematsu Y; Ikushima I; Kira T; Liang L; Ushio Y; Takahashi M
AJNR Am J Neuroradiol; 2000 May; 21(5):901-9. PubMed ID: 10815666
[TBL] [Abstract][Full Text] [Related]
38. Cerebral blood volume measurements and proton MR spectroscopy in grading of oligodendroglial tumors.
Spampinato MV; Smith JK; Kwock L; Ewend M; Grimme JD; Camacho DL; Castillo M
AJR Am J Roentgenol; 2007 Jan; 188(1):204-12. PubMed ID: 17179366
[TBL] [Abstract][Full Text] [Related]
39. Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy.
Floeth FW; Pauleit D; Wittsack HJ; Langen KJ; Reifenberger G; Hamacher K; Messing-Jünger M; Zilles K; Weber F; Stummer W; Steiger HJ; Woebker G; Müller HW; Coenen H; Sabel M
J Neurosurg; 2005 Feb; 102(2):318-27. PubMed ID: 15739561
[TBL] [Abstract][Full Text] [Related]
40. Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors.
Bulakbasi N; Kocaoglu M; Ors F; Tayfun C; Uçöz T
AJNR Am J Neuroradiol; 2003 Feb; 24(2):225-33. PubMed ID: 12591638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
